Syntocinon
DrugOxytocin nasal spray
Other names: Oxytocin
NCT Number: NCT02508220
The study compares the short-term tinnitus reduction following a single oxytocin intervention with a placebo control condition.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oxytocin nasal spray
Other names: Oxytocin
distilled water in nasal spray
Other names: distilled water
Time frame: 30 minutes after intervention
Time frame: 30 minutes after intervention
Time frame: within one hour before intervention
measured in dB HL
Time frame: within one hour before intervention
measured in dB HL
Time frame: within one hour before intervention
Frequency measured in Hz
Berthold Langguth, MD, Ph.D.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02615600
Chronic Tinnitus, Ear Diseases
Regensburg, Germany
View Trial DetailsNCT07324603
Chronic Tinnitus
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT01407133
Chronic Tinnitus
Lyon, France
View Trial DetailsNCT03550430
Chronic Tinnitus, Ear Diseases
Marburg, Hesse, Germany
View Trial Details